Evidence map›Paper›PMID 33538037›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2021

Graphene: A Disruptive Opportunity for COVID-19 and Future Pandemics?

Giacomo Reina, Daniel Iglesias, Paolo Samorì, Alberto Bianco

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. High-breathable, antimicrobial and water-repellent face mask for breath monitoring.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Lignin: A Sustainable Antiviral Coating Material.ACS sustainable chemistry & engineering · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Masks for COVID-19.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  14. Review
  15. Graphene: A Disruptive Opportunity for COVID-19 and Future Pandemics?Advanced materials (Deerfield Beach, Fla.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giacomo ReinaCNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France.
Daniel IglesiasUniversity of Strasbourg, CNRS, ISIS, Strasbourg, 67000, France.
Paolo SamorìUniversity of Strasbourg, CNRS, ISIS, Strasbourg, 67000, France.
Alberto BiancoCNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg, 67000, France.ORCID https://orcid.org/0000-0002-1090-296X

Funding

Centre National de la Recherche ScientifiqueERC GA-833707International Center for Frontier Research in Chemistry GA-881603LabEx project Chemistry of Complex Systems ANR-10-LABX-0026_CSC
6 · The paper itself

Abstract

The graphene revolution, which has taken place during the last 15 years, has represented a paradigm shift for science. The extraordinary properties possessed by this unique material have paved the road to a number of applications in materials science, optoelectronics, energy, and sensing. Graphene-related materials (GRMs) are now produced in large scale and have found niche applications also in the biomedical technologies, defining new standards for drug delivery and biosensing. Such advances position GRMs as novel tools to fight against the current COVID-19 and future pandemics. In this regard, GRMs can play a major role in sensing, as an active component in antiviral surfaces or in virucidal formulations. Herein, the most promising strategies reported in the literature on the use of GRM-based materials against the COVID-19 pandemic and other types of viruses are showcased, with a strong focus on the impact of functionalization, deposition techniques, and integration into devices and surface coatings.

Indexed as

Antibodies, ImmobilizedAntiviral AgentsBiosensing TechniquesCOVID-19Electrochemical TechniquesElectrodesGraphiteHumansLimit of DetectionNanostructuresSARS-CoV-2Surface PropertiesViral ProteinsAntibodies, ImmobilizedAntiviral AgentsGraphiteViral Proteins2D materialsantimicrobialscarbon nanomaterialsSARS-CoV-2sensing

Identifiers

PMID33538037
PMCPMC7995107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.